Select a Region

North America

Newscenter

Read our latest news!

Posted on June 29, 20226/29/22

Accord BioPharma and EVERSANA Announce Partnership to Support the Launch of CAMCEVI® for the Treatment of Advanced Prostate Cancer in Adults in the U.S.

Posted on June 7, 20226/7/22

EVERSANA™ Unveils EVERSANA INTOUCH, a Next-Generation Agency Network Delivering Award-Winning Creative, Digital, and Global Market Access Solutions for Life Sciences

Posted on June 2, 20226/2/22

EVERSANA and Limitless Minds Advance Pharmaceutical Sales Performance with New Cognitive & Behavioral Training Solution

EVERSANA

Posted on May 17, 20225/17/22

Four EVERSANA Leaders Named to 2022 PM360 ELITE 100

Posted on April 28, 20224/28/22

EVERSANA™ and Vector Pharma FZCO Announce Strategic Partnership to Expand Commercialisation Services Throughout Middle East and North Africa

EVERSANA

Posted on April 27, 20224/27/22

EVERSANA Announces European Expansion with New Location in the United Kingdom

Posted on April 14, 20224/14/22

EVERSANA and UpScriptHealth Announce Integrated, Direct-to-Patient Platform, Transforming the Patient Journey to Accelerate Therapy Access, Affordability and Adherence

Posted on March 22, 20223/22/22

EVERSANA’s Data & Analytics Platform ACTICS by EVERSANA Named a 2022 Artificial Intelligence Award Winner

Posted on March 17, 20223/17/22

EVERSANA unveils global price and market access solution NAVLIN by EVERSANA

EVERSANA

Posted on February 28, 20222/28/22

Rare Disease Day 2022: A Message from EVERSANA CEO Jim Lang

Discover EVERSANA

Resource Center
We’re driven by a diverse team of experts who understand the challenges facing today's industry.
Learn More
Experts
We’re driven by a diverse team of experts who understand the challenges facing today's industry.
Experts